PropertyValue
?:abstract
  • One of the most significant negative prognostic factors in patients suffering from the disease caused by SARS-CoV-2 (COVID-19) is the development of coagulopathy, associated with abnormal laboratory findings, such as increased D-dimer, and venous thromboembolic complications, requiring thromboprophylactic strategies. The main clinical characteristics of COVID-19 patients are revised here as compared to other coronavirus infections, such as Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS), emphasizing clinical, diagnostic and therapeutic aspects.
?:creator
?:journal
  • An_Sist_Sanit_Navar
?:license
  • unk
?:publication_isRelatedTo_Disease
?:source
  • WHO
?:title
  • [Coagulopathy and thrombosis: similarities and differences among pathogenic coronaviruses]
?:type
?:who_covidence_id
  • #725271
?:year
  • 2020

Metadata

Anon_0  
expand all